Will Nike's Stock Price Sink to $23? Here Are the Bear, Base, and Bull Cases Over the Next Year.

Nike shares have fallen nearly 50% over the past 12 months to $36.80, while analyst targets range from $23, implying 37.5% downside, to $75, implying 103.8% upside by September 2027. Fiscal 2026 Greater China revenue declined 11% to $5.8 billion and Converse revenue fell 31% to $1.2 billion, offsetting a 6% increase in wholesale revenue to $27.5 billion. The median analyst target is $46, or 25% upside, but the article argues investors should wait for several consecutive quarters of turnaround progress.

Analysis

NKE is no longer primarily a brand-recovery trade; it is an execution-duration trade. The market can tolerate weak legacy categories if wholesale reacceleration converts into cleaner inventory turns and reduced promotional intensity, but it will not underwrite a premium multiple until North America demand, China stabilization, and gross-margin recovery move together. The key near-term read-through is whether wholesale growth is incremental rather than merely channel-shifted from direct-to-consumer sales.

Greater China weakness creates a competitive opening for ANTA Sports, Li Ning and local performance brands, while Adidas (ADS.DE) and On Holding (ONON) can gain global shelf space if Nike’s product reset remains slow. Converse deterioration is economically modest but strategically relevant: it suggests the issue extends beyond one geography and points to franchise aging, raising the cost of marketing and product refresh necessary to restore growth. That cost could delay EBIT-margin normalization even if revenue bottoms first.

Consensus appears focused on the wide dispersion of published targets rather than the earnings path needed to justify either outcome. A tradable upside case requires two consecutive quarters of improving constant-currency sales, lower markdowns, and reaffirmed gross-margin expansion; absent that, each weak quarterly print risks another de-rating because the stock lacks a clear estimate-revision floor. Over 6-18 months, a successful wholesale reset could improve working-capital efficiency, but this is not yet independently validated by segment-level channel profitability or inventory data.

Contrarian view: expectations may be sufficiently depressed for a sharp relief rally on modest evidence of stabilization, but that is different from a durable turnaround. Avoid treating a product-launch narrative as proof of demand elasticity until sell-through, reorder rates, and full-price mix improve.

Key Decisions for Investors

• Maintain NKE at underweight/watch rather than initiate a directional long before the next two earnings reports. Upgrade only after two quarters of positive constant-currency revenue progression and gross-margin guidance that is raised or reaffirmed; failure on either metric supports a retest of the downside valuation range.
• For a tactical 1-3 month trade, consider a defined-risk NKE call spread only after an earnings-driven gap higher is accompanied by above-average volume and management confirms lower promotional activity. Target a 15-20% rebound; cut if the post-earnings low breaks, as that would signal estimate revisions remain negative.
• Express competitive substitution through long ONON versus short NKE on a 6-12 month horizon. ONON offers cleaner premium-growth and innovation exposure, while NKE carries China, margin-reinvestment, and turnaround-timing risk; exit if NKE demonstrates sustained full-price sell-through and ONON’s growth decelerates materially.
• Monitor ANTA Sports and Li Ning quarterly China sell-through and market-share commentary as leading indicators. Improving local-brand momentum alongside further NKE China weakness would argue against owning NKE into results; a broad China athletic-footwear recovery with NKE underperforming would isolate company-specific execution risk.